Regrowth resistance in cancer: why has it been largely ignored? - Wikidata - awgldk - TriplyDB

Regrowth resistance in cancer: why has it been largely ignored?

Regrowth resistance in cancer: why has it been largely ignored?

http://www.wikidata.org/entity/Q40455407

about

Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin's lymphoma.

P2860

Q43653725-F8B0277F-9056-4613-8B39-13BE6A87A2BD

P2860

Regrowth resistance in cancer: why has it been largely ignored?

http://www.wikidata.org/entity/Q40455407

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

1995年论文

@zh

1995年论文

@zh-cn

name

Regrowth resistance in cancer: why has it been largely ignored?

@en

type

label

Regrowth resistance in cancer: why has it been largely ignored?

@en

prefLabel

Regrowth resistance in cancer: why has it been largely ignored?

@en

P1433

Q40455407-609CFB99-49C6-4A8B-865B-578DB2E20A3A

P1476

Q40455407-7ABB0DEE-2984-4357-88BF-E96E8987BA07

P2093

Q40455407-007AEA30-3450-4872-B692-48C5585296D5

Q40455407-BC7D5077-F8DC-4194-99D6-3F7679F39F37

P2860

Q40455407-0C8DF20C-1803-4D99-8A07-DDDEB8CB1607

Q40455407-0DA8A06F-4E6B-4908-962B-9405E60B705D

Q40455407-24AAFD05-09F0-4104-ADB7-C296CAFE1628

Q40455407-37A9986B-DCD6-49B0-8F2D-68C136A2DF0E

Q40455407-3C416C82-A2DD-495A-96B3-263C4FE55FE1

Q40455407-7C56CDB3-F191-49B9-91BF-010077256C0F

Q40455407-95527206-61ED-4F3D-A58F-2FF22C7F94CB

Q40455407-A8CE89B2-6862-4D98-9661-B6F4E2FEB56B

Q40455407-AEC94D37-6554-4C78-858F-B358FAAE2574

Q40455407-B1E60528-1A4B-4E60-B2D6-E10E9EE2B736

P304

Q40455407-17EB58A9-5068-4317-81E5-0854DACF4746

P31

Q40455407-B2B6FF4B-D543-4BF8-BE62-834437FEB5A4

P356

Q40455407-F172F6DF-AD4B-45D4-82DF-687740F65CBE

P433

Q40455407-1E4D5D46-AA8E-46C4-B590-9CE2D43FC761

P478

Q40455407-94E80E27-4445-4ADE-BF93-842FA9AC8D95

P577

Q40455407-0073FA29-C5E7-48C4-B0ED-0AD4D6E5DB7F

P698

Q40455407-8D64F035-34B9-4464-A04A-8952CA4225A3

P356

J.1365-2184.1995.TB00076.X

P1433

Cell Proliferation

P1476

Regrowth resistance in cancer: why has it been largely ignored?

@en

P2093

Preisler HD

http://www.w3.org/2001/XMLSchema#string

Venugopal P

http://www.w3.org/2001/XMLSchema#string

P2860

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.

Some reasons for the lack of progress in the treatment of acute myelogenous leukemia: a review of three consecutive trials of the treatment of poor prognosis patients.

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.

Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.

Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.

Cell kinetic analyses of human malignant brain tumors (gliomas).

Regrowth resistance in leukemia and lymphoma: the need for a new system to classify treatment failure and for new approaches to treatment.

Treatment of non-Hodgkin's lymphoma.

Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group Protocol

P304

347-356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2184.1995.TB00076.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

1995-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7626689

http://www.w3.org/2001/XMLSchema#string